- Home
- BDX
as 05-30-2025 4:00pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 58.9B | IPO Year: | 1962 |
| Target Price: | $235.63 | AVG Volume (30 days): | 3.6M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.16 | EPS Growth: | 14.07 |
| 52 Week Low/High: | $163.33 - $251.99 | Next Earning Date: | 05-01-2025 |
| Revenue: | $20,867,000,000 | Revenue Growth: | 5.84% |
| Revenue Growth (this year): | 9.28% | Revenue Growth (next year): | 4.92% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Garrison Michael David | BDX | EVP & President, Medical | Apr 9 '25 | Sell | $197.28 | 479 | $94,497.12 | 4,887 | |
| Byrd Richard | BDX | EVP & President Interventional | Mar 18 '25 | Sell | $230.00 | 459 | $105,570.00 | 6,952 | |
| Byrd Richard | BDX | EVP & President Interventional | Mar 12 '25 | Sell | $224.91 | 1,940 | $436,325.40 | 6,952 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
Zacks
a day ago
BD Stock Might See Short-term Decline After Warning on Tamponade Tubes
Medical Device Network
3 days ago
BD to launch registry study of atherectomy system for PAD treatment
PR Newswire
4 days ago
BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
PR Newswire
4 days ago
BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference
StockStory
9 days ago
3 Value Stocks Facing Headwinds
MT Newswires
10 days ago
Citigroup Downgrades Becton Dickinson and Co. to Neutral From Buy, Adjusts PT to $185 From $217
PR Newswire
11 days ago
Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'
Zacks
12 days ago
BD Stock May Rise Following the Launch of FACSDiscover A8 Platform
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.